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In a recent Lancet publication, we reported the findings of a stepped-wedge, cluster randomised trial 
of a quality improvement intervention to enhance the outcomes of emergency abdominal surgery [1]. 
In this editorial we summarise the possible factors that led to the failure of the intervention to impact 
on patient outcomes and what has been learnt from the trial. 
 
The Enhanced Peri-Operative Care for High-risk patients (EPOCH) trial had two interventions: a 37-
component care-pathway, representing best care for this patient group and a quality improvement 
programme designed to support implementation of the pathway in 93 hospitals across the UK. 
National Health Service (NHS) hospitals contributing to the National Emergency Laparotomy Audit 
were eligible for inclusion [2]. Local improvement leads from each perioperative discipline (surgery, 
anaesthesia, and critical care) were responsible for leading hospital wide improvement efforts to 
implement the care pathway. The quality improvement programme was designed to support these 
local clinicians and comprised of educational meetings, a virtual learning environment and telephone 
/ email support from the national EPOCH team. The programme was designed to be typical of NHS 
improvement efforts at the time and had minimal face-to-face contact time, recognising the limited 
resources of the study and of clinician time within the NHS. Full details about the EPOCH improvement 
programme are reported elsewhere [3]. The intervention ran for 80 weeks in total (the first cluster 
began the intervention 5 weeks into the study), with one cluster commencing the intervention every 
5-week step from the second to the 16th time period. 
 
The primary objective of the EPOCH trial was to reduce 90-day mortality from 25% to 16%. Both the 
intervention and usual care groups had a 90-day mortality of 16%. The most frequently enrolled 
patients had intestinal obstruction or perforation. Process measures indicate that the intervention 
group were more likely to have preoperative documentation of risk, to receive goal directed fluid 
therapy and to have serum lactate measured at the end of surgery than the usual care group. Other 
key process improved less, such as patients entering the operating theatre within their target 
timeframe, critical care admission post-operatively and consultant decision to operate. Secondary 
outcomes, including 180-day mortality, length of stay, and readmissions, also did not differ between 




Why didn’t the EPOCH interventions work? 
The trial process evaluation revealed good engagement with the quality improvement programme 
amongst clinicians but limited time and resources for staff to implement change. There were wide 
variations in intervention fidelity between hospitals, with differences in the both the components 
within the care-pathway that teams tried to implement first, and the quality improvement approaches 
teams used to make change happen. This created wide variations in the rate of change and eventual 
success across the 93 hospitals. The trial hypothesis was based on the belief that limited awareness of 
poor outcomes was the primary barrier to better patient care. In reality, the reasons for poor quality 
care were much more complex. As a result, local EPOCH teams were asked to tackle too many parts 
of the patient care pathway, with insufficient quality improvement support and training, and perhaps 
most importantly, in too short a timeframe. Whilst patient survival did not improve, EPOCH provided 




There is some debate regarding the value of large trials which frequently fail to confirm the clinical 
effectiveness of interventions. There is too much emphasis on trials with ‘positive’ findings, prioritising 
publication of trials of interventions that ‘work’ whilst failing to appreciate the wealth of clinical 
information provided by a well-conducted clinical trial, whether ‘positive’ or ‘negative’. This reflects 
frustration in the clinical community when a treatment or intervention simply does not deliver on the 
initial promise when it is rigorously evaluated. So, what are the lessons from a ‘negative trial’ like 
EPOCH? Firstly, we do not doubt the value of the core clinical components of the intervention but 
rather the methods for improving care at the frontline. Improvement science has developed 
substantially since the EPOCH trial was designed back in 2012-13 and improvement methods, such as 
audit and feedback and the Plan-Do-Study-Act cycle, may well be effective. They are not, however, 
quick and easy fixes to a problem, and require adequate manpower, a realistic timeframe and enough 
resource to make them work. Also, some system-level improvements, such as reducing the time taken 
to get the patient to surgery, may be beyond the scope of what frontline clinicians can change by 
themselves. Quality improvement projects cannot make up for major structural issues such as too few 
emergency operating theatres. Without addressing these issues, quality improvement efforts led by 
frontline colleagues will continue to fail. Next, by doing EPOCH we have confirmed what is necessary 
to trial a complex intervention such as a quality improvement programme; not only does the trial 
design need to account for temporal trends toward improvement (the so called secular trend) but also 
requires careful consideration of which process measures to collect and to integrate a mixed methods 
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process evaluation, to detail what happened ‘on the ground’ during the trial. If we had run the EPOCH 
trial without these additional research elements it would have been a genuinely negative result, as we 
would not have understood why we got the result we did. 
 
Improving emergency surgical care 
The volume and acuity of emergency general surgery will continue to increase with our aging, multi-
morbidity population [4]. Whilst the EPOCH trial did not result in improved outcomes, it must not 
deter future efforts to improve care. Indeed, by clearly outlining the challenges involved in reducing 
variation and implementing best practices, for patients requiring emergency general surgery, we hope 
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